Medichem (India) Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 15-07-2024
- Paid Up Capital ₹ 0.27 M
as on 15-07-2024
- Company Age 41 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.90 M
as on 15-07-2024
- Satisfied Charges ₹ 2.50 M
as on 15-07-2024
- Revenue -0.23%
(FY 2022)
- Profit 5.55%
(FY 2022)
- Ebitda 65.10%
(FY 2022)
- Net Worth 3.17%
(FY 2022)
- Total Assets -4.87%
(FY 2022)
About Medichem (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.27 M.
The company currently has active open charges totaling ₹3.90 M. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Aloke Sarkar and Priti Sarkar serve as directors at the Company.
- CIN/LLPIN
U24119WB1983PTC036997
- Company No.
036997
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
North 24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medichem (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aloke Sarkar  | Director | 09-Dec-1983 | Current |
| Priti Sarkar | Director | 17-May-2007 | Current |
Financial Performance and Corporate Structure Insights of Medichem (India).
Medichem (India) Pvt Ltd, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.23% decrease. The company also saw a slight improvement in profitability, with a 5.55% increase in profit. The company's net worth moved up by a moderate rise of 3.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medichem (India)?
Unlock access to Medichem (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bengal National Chamber Of Commerce & IndustryActive 84 years 3 monthsAloke Sarkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Jun 2022 | ₹0.70 M | Open |
State Bank Of India Creation Date: 22 Apr 2019 | ₹3.20 M | Open |
State Bank Of India Creation Date: 26 Mar 2004 | ₹2.50 M | Satisfied |
How Many Employees Work at Medichem (India)?
Medichem (India) has a workforce of 2 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medichem (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medichem (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
